Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Aplex Bio AB
AB
Active
Org 5592482870
Nobels Väg 16, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Aplex Bio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2020
0M
2021
0M
2022
2M
2023
1M
2024
EBITDA
SEK millions
0M
-1M
-1M
-2M
-3M
0M
2020
0M
0%
2021
-1M
-100%
2022
-1M
0%
2023
-2M
-100%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
292
1 613
1 263
Staff expenses
—
—
−3 235
−4 635
−5 274
EBITDA
−164
−430
−909
−828
−1 784
Depreciation & amort.
−0
−0
−61
−99
−112
EBIT
−164
−430
−971
−927
−1 896
Net financials
—
—
4
93
102
Profit before tax
−164
−430
—
−835
−1 794
Tax
−0
−0
—
—
—
Net profit
−164
−430
−966
−835
−1 794
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
6 184
14 035
13 729
20 735
30 326
Equity
5 963
13 642
12 675
20 027
28 743
Long-term debt
0
0
—
—
—
Short-term debt
221
393
1 053
708
1 583
Total debt
221
393
1 053
708
1 583
Financial ratios
5-year trend
EBITDA margin
-141.3%
This company
15.8%
Market median
-994% vs market
2020
2024
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
2020
2024
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
2020
2024
Net profit margin
-142.1%
This company
8.1%
Market median
-1854% vs market
2020
2024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
View
PDF
More on Aplex Bio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
